Antifungal, amoebicidal, and cytotoxic activities of Cleistanthus bracteosus Jabl (Phyllanthaceae) bark extracts in vitro
Abstract
Endemic plants in the primary rainforests of Malaysia may serve as sources of natural products with the potential to be developed into lead therapeutic compounds. One such plant is Cleistanthus bracteosus Jabl. Hexane, ethyl acetate, and methanol extracts of the bark of C. bracteosus were examined for antifungal and anti-acanthamoeba activities using microbroth dilution techniques, while cytotoxic activities were assessed using the sulforhodamine B colorimetric assay. Phytochemical screening and analyses, including GC-MS, ¹H-NMR, LC-MS, and FT-IR, were conducted to provide insights into the chemical composition of the extracts. The methanol extract of bark inhibited the growth of Candida auris and Candida albicans (MIC: 10 mg/mL) as well as the survival of the cysts and trophozoites of four strains of Acanthamoeba. It also demonstrated selective cytotoxic activity against ovarian cancer cells (IC₅₀: 46 µg/mL). Phytochemical screening and spectroscopic analyses indicated the presence of lignans, flavonoids, and tannins. C. bracteosus produces natural products, including lignans, flavonoids, and tannins, which may hold potential for the development of agents to combat C. auris infections and ovarian cancer. Further phytochemical studies are warranted.